Home > Insider Trading > Filing (0001209191-23-009301)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124140	Exact Sciences Corp	EXAS	Services-Medical Laboratories (8071)	204782291

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1306119	T Kevin Conroy	C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-02-10	9,705	$0.00	1,177,632	No	4	M	Direct
Common Stock	Disposition	2023-02-13	4,527	$64.55	1,173,105	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Units	Disposition	2023-02-10	9,705	$0.00	9,705	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	27,099	Indirect	Held in 401(k) Plan
Common Stock	21,730	Indirect	Held in Grantor Retained Annuity Trust
Common Stock	21,730	Indirect	Held in Grantor Retained Annuity Trust
Common Stock	21,729	Indirect	Held in Grantor Retained Annuity Trust

Footnotes

Represents shares of common stock received upon settlement of a performance share unit award (the "PSU Award") on February 10, 2023, which is described further in Footnote 5 to this Form 4.
Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units on February 10, 2023.
In addition to the shares of Common Stock reported on this Form 4, which total 1,265,393 shares, Mr. Conroy also holds, in the aggregate, an additional 761,440 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Each Performance Share Unit represents a right to receive one share of common stock.
On February 22, 2022, Mr. Conroy agreed to accept performance vesting stock units ("PSUs") in lieu of one-half of his bonus opportunity for 2022. The amount of the PSUs that ultimately vested was equal to the percentage of the bonus opportunity that was paid to bonus plan participants based on the achievement of corporate goals established for such plan.